Letters by company
Moderna, Inc.
5 letters discussing MRNA. Everything written about it on this site is on its ticker page.
- WestEnd Capital Management Third Quarter 2026 / Strategy Update and Market Overview WestEnd's Core Strategy broadened health-care exposure, adding GE HealthCare, Merck and Moderna while exiting Boeing after its production recovery repeatedly faltered. The portfolio added Meta Platforms, Palantir and Snowflake, arguing that each has a clearer route to monetizing enterprise or consumer AI spending amid higher rates. Third Quarter 2026 BA $131BMETA $1.6TMRNA $87B
- Andrew Hill Investment Advisors The Client Letter: Pivoting Investment Strategy Andrew Hill Investment Advisors expects pandemic-driven supply constraints to ease while labor and housing shortages keep longer-term inflation elevated. The firm harvested gains in speculative growth holdings, shifted from Nvidia to Apple, and favors recurring-revenue growth companies, renewable energy, financials and healthcare as Federal Reserve policy tightens. Year to Date (as of December 15, 2021) AAPL $5.1TABBNY $152BABBV $521B
- Hotchkis & Wiley Mid-Cap Value Fund Manager Review & Economic Outlook The Mid-Cap Value Fund trimmed Workday after takeover speculation and retained its investment case for APA, Olin, SLM Corp, and NRG Energy despite stock-specific setbacks. The portfolio favors financially sound value businesses as higher rates, oil-market disruption, and fading AI enthusiasm shifted market leadership toward value and quality. 3Q26 APA $16BNRG $20BOLN $1.9B
- Montaka Global Investments Quarterly Update for September 2026: AI Risk and Bond Yields Montaka sold TSMC and REA Group despite viewing both as competitively advantaged, reallocating toward cloud computing and increasing Uber while trimming Salesforce and Moderna after rallies. The portfolio argues that AI-driven cyber and regulatory risks are rising, while higher yields and fiscal refinancing needs are creating debt-trap risks for heavily indebted governments. Q3 2026 453950 RPGRF $23B
- Andrew Hill Investment Advisors Hurricane Ian Edition of the Client Letter/4Q2022 Andrew Hill Investment Advisors cut equity exposure, added an S&P 500 short position and kept bond maturities short with high credit quality as the Federal Reserve raised rates. The firm favored energy-transition holdings and rebuilding beneficiaries, while waiting for bond yields and earnings expectations to stabilize before extending duration or taking more equity risk. Q3 2022 NEE $179BTSLA $1.5T